EDUCATIONAL WEBINAR: Evidence-Based Strategy in the Prevention of Complications due to Retained Blood

An Educational Webinar with Presenters: Marc Gillinov, MD, Marc Gerdisch, MD, and Alyson Mehringer, RN discussing the basic principles of Chest Tube Management, the results of a 1 year quality improvement study and the operational perspective from the ICU Nursing Staff.



Medical Device Start Up Clear Catheter Systems Raises $1.2 Million

Medical Device Start Up Clear Catheter Systems Raises $1.2 Million

Bend, OR—October 5, 2010—Clear Catheter Systems, Inc, developer of innovative
medical technologies for medical tube clearance, today announced it has closed an
equity financing round with total proceeds of $1.2 million. The financing was led by the
Oregon Angel Fund (OAF), joined by additional Oregon based angel investors. The
financing will support the clinical launch of the companyʼs lead product, the
PleuraFlow® Active Tube Clearance® System and continued technology development.

“We are very pleased to have the OAF join our investor syndicate and we welcome Jim
Fee from the OAF to our Board of Directors,” said Edward Boyle, Chief Executive
Officer of Clear Catheter Systems. “Jimʼs extensive experience in building global

medical device marketing and sales teams will be of tremendous value to us as we

move forward with our commercialization efforts.”

“The PleuraFlow® Active Tube Clearance® System is a groundbreaking product to help
make heart and lung surgery safer and more cost effective,” said Jim Fee of Oregon
Angel Fund. “We are excited to support the company in accelerating the adoption of this
innovative solution to a common problem faced in hospitals daily.”

About Clear Catheter Systems, Inc.
Clear Catheter Systems is a Bend, Oregon based medical device company developing
an anti-clogging platform of surgical drainage devices. Its lead product is the
PleuraFlow® Catheter. In addition, Clear Catheter has a pipeline of products based on its
proprietary tube clearance technology to treat tube clogging in other medical market
segments, including a system for the urinary catheter drainage market, the enteral
feeding sector as well as systems for standard surgical drains. (

About the Oregon Angel Fund
The Oregon Angel Fund (OAF) is a highly structured, professionally managed, investordriven
angel fund. The fund provides accredited investors privileged access to the most
promising startups and early-stage growth companies in Oregon and SW Washington.
OAF launches a new $3M+ fund each spring. Each annual fund aims to place 4-5
investments over a 12-month active investing period, followed by another 10 years of
fund life to grow and exit each portfolio. The fund typically invests $400k-$600k per deal
with individual OAF members and venture capitalists investing alongside and after OAF.

PleuraFlow® is a registered trademark of Clear Catheter Systems. Other company and
product names may be trademarks of their respective owners.

Media Contact
Kelly Herman
(541) 419-8855